Healthcare - Biotechnology - NASDAQ - US
$ 2.62
-8.07 %
$ 148 M
Market Cap
-2.15
P/E
BALANCE SHEET
159 M
ASSETS
41.8 M
LIABILITIES
117 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Black Diamond Therapeutics, Inc.
| Current Assets | 134 M |
| Cash & Short-Term Investments | 131 M |
| Receivables | 0 |
| Other Current Assets | 2.63 M |
| Non-Current Assets | 24.5 M |
| Long-Term Investments | 0 |
| PP&E | 23.7 M |
| Other Non-Current Assets | 823 K |
| Current Liabilities | 19.6 M |
| Accounts Payable | 2.32 M |
| Short-Term Debt | 3.11 M |
| Other Current Liabilities | 14.2 M |
| Non-Current Liabilities | 22.2 M |
| Long-Term Debt | 22.2 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 56.2 | 34.3 | 65.8 | 34.6 | 154.7 | 51.7 | 7.9 |
| Short Term Investments | 75.2 | 88.5 | 144.0 | 280.5 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.6 | 4.9 | 5.9 | 4.5 | 2.1 | 24 K | 36 K |
| Total Current Assets | 134.0 | 127.7 | 209.8 | 319.6 | 154.7 | 51.7 | 7.9 |
| PP&E | 23.7 | 27.4 | 30.7 | 8.8 | 0.2 | 0.1 | 0.1 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.2 | 1.2 | 1.2 | 55 K | 0 | 0 |
| Other Long Term Assets | 0.8 | 0 | 5.9 | 0.1 | 3.4 | 8 K | 5 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 158.6 | 156.3 | 247.7 | 329.7 | 158.3 | 51.8 | 8.0 |
| LIABILITIES | |||||||
| Accounts Payable | 2.3 | 1.9 | 4.1 | 2.5 | 2.0 | 0.4 | 0.2 |
| Short Term Debt | 3.1 | 2.8 | 0.3 | 1.0 | 0 | 0 | 0 |
| Other Current Liabilities | 14.2 | 10.5 | 19.2 | 10.6 | 2.9 | 2.2 | 2.1 |
| Total Current Liabilities | 19.6 | 15.3 | 23.6 | 14.2 | 4.9 | 2.6 | 2.2 |
| Long Term Debt | 22.2 | 25.3 | 28.1 | 7.7 | 0 | 60.8 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 200.6 | 4.0 | 12.5 |
| Total Liabilities | 41.8 | 40.6 | 491.5 | 21.9 | 209.3 | 67.4 | 14.7 |
| EQUITY | |||||||
| Common Stock | 7 K | 5 K | 5 K | 5 K | 1 K | 1 K | 1 K |
| Retained Earnings | (417.4) | (335.0) | (243.8) | (118.2) | (51.0) | (15.7) | (6.8) |
| Other Accumulative Comprehensive Income/Loss | 27 K | (1.8) | (0.4) | 0.6 | 1 K | 100 K | 56 K |
| Total Equity | 116.7 | (335.0) | (243.8) | (118.2) | (51.0) | (15.5) | (6.7) |
| Total Liabilities and Equity | 158.6 | (294.4) | 247.7 | (96.3) | 158.3 | 51.8 | 8.0 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 44.0 | 36.3 | 36.2 | 32.9 | 35.9 | 14.0 | 7.2 |